In every family, there exists a pivotal story—one where intuition guides a parent to uncover the truth about their child’s well-being. This is a tale of unyielding maternal instinct that can help safeguard their loved ones.
For Jessica Adams, that instinct kicked in shortly after the birth of her youngest son, Leo. Born at 36 weeks and weighing only four pounds and 12 ounces, Leo demonstrated unusual strength from a young age. At just two weeks old, he was rolling over, and Jessica couldn’t shake the feeling that something was amiss. Despite his early milestones, he seemed too active for a newborn who should still be nestled in the womb. Jessica and her husband, Tom, quickly sought the help of a physical therapist, and while some issues began to improve, new concerns soon arose.
By the time Leo was three months old, Jessica noticed troubling eating patterns. He would appear hungry but struggled to eat, and soon after, respiratory problems emerged, leading to halted growth. Jessica’s intuition screamed that something was fundamentally wrong, even as doctors reassured her that all was well. After several hospital visits for failure to thrive and being told Leo was merely “adjusting,” Jessica’s convictions only grew stronger.
Despite every test returning normal results and even facing unfounded accusations from child services—a reality faced by many families dealing with rare conditions—Jessica refused to relent. Her determination only intensified, leading to the diagnosis that would change everything. At 11 months old, Leo was diagnosed with Spinal Muscular Atrophy with Respiratory Distress (SMARD1), an ultra-rare and often fatal neurodegenerative disorder. The news was crushing; the doctors informed them there were no available treatments, leaving the family to cherish the time they had left together.
But Jessica was not willing to accept that fate. She and Tom resolved to take matters into their own hands. They established a nonprofit organization, Smash SMARD, dedicated to funding gene therapy research for conditions related to IGHMBP2 disorders. Their mission is to ensure families like theirs are not told there are no treatment options available. Jessica’s unwavering spirit has helped them raise over two million dollars to propel gene therapy into clinical trials at the Abigail Wexner Research Institute at Nationwide Children’s Hospital.
“As a mother, if you sense something is wrong, don’t hesitate to advocate for your child,” Jessica urges. “If you’re told there are no options, remember, there’s always a way to create one.” The Stinemans continue their fight, needing to raise an additional 250 thousand dollars to reach their next goal.
Now four years old, Leo faces daily challenges; he cannot walk or talk as most children do and relies on a ventilator for sleep. He requires regular medical attention, yet he remains a joyful child, captivated by anything with wheels and adoring his older brother, Max. For Jessica, each moment with Leo is a precious gift.
The clinical trial represents a beacon of hope, stemming from a mother’s love and an unwavering commitment to not only protect her son but also to pave the way for others facing similar battles.
For more insights, check out this article on home insemination and visit Intracervical Insemination for expert advice. For pregnancy resources, March of Dimes offers excellent guidance.
Search Queries:
- Home insemination kit
- Self insemination techniques
- How to find a sperm donor
- Best home insemination methods
- Pregnancy week by week guide
In summary, Jessica Adams embodies the relentless spirit of a mother determined to change the narrative for her son and others like him. Through her nonprofit, Smash SMARD, she is leading the charge against a rare disease, fueled by love and hope for a brighter future.